Acurx Pharmaceuticals, Inc.

ACXP ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
S-1 Sep 14, 2022 FORM S-1
8-K Aug 15, 2022 FORM 8-K
10-Q Aug 12, 2022 10-Q
4 Jul 29, 2022 OWNERSHIP DOCUMENT
4 Jul 29, 2022 OWNERSHIP DOCUMENT
4 Jul 29, 2022 OWNERSHIP DOCUMENT
424B5 Jul 25, 2022 424B5
8-K Jul 25, 2022 FORM 8-K
EFFECT Jul 11, 2022
CORRESP Jul 7, 2022
UPLOAD Jul 7, 2022
S-3 Jul 1, 2022 FORM S-3
8-K Jun 7, 2022 FORM 8-K
8-K May 11, 2022 FORM 8-K
10-Q May 10, 2022 10-Q
DEFA14A Apr 25, 2022 DEFA14A
DEF 14A Apr 25, 2022 DEF 14A
8-K Mar 17, 2022 FORM 8-K
S-8 Mar 16, 2022 FORM S-8
10-K Mar 16, 2022 10-K
4 Nov 24, 2021 OWNERSHIP DOCUMENT
4 Nov 22, 2021 OWNERSHIP DOCUMENT
4 Nov 22, 2021 OWNERSHIP DOCUMENT
8-K Nov 16, 2021 FORM 8-K
10-Q Nov 12, 2021 FORM 10-Q
← Newer Page 8 of 10 · 243 filings Older →